Acta Philosophica Gothoburgensia No. 9.
310 pages in English. Acta
Universitatis Gothoburgensis, Göteborg
1999.
REVIEWS
OF THIS BOOK
Keywords: assisted procreation, bioethics, embryo experimentation, eugenics, genetic testing, in vitro fertilisation, medical ethics, medical genetics, polar body biopsy, preconception diagnosis, preimplantation genetic diagnosis, prenatal diagnosis, public policy, reproductive medicine, research ethics, sex preselection.
© Christian Munthe, 1999
Distribution:
ACTA
UNIVERSITATIS
GOTHOBURGENSIS
Box 222, SE-405 30 Göteborg, Sweden
ISBN 91-7346-362-0
ISSN 0283-2380
FOREWORD 11
Chapter 1: INTRODUCTION 14
The Issues 16
Particular Applications 16Plan of the Book 18
Policy Issues 17
Research Ethics 17
Background 20
The Rise of PGD versus Prenatal Diagnosis 20Chapter 2: THE RISE OF PGD IN SWEDEN: A CASE STUDY 35
Ethical Debate Among Medical Specialists 22
Current Techniques and Procedures 24
Future Prospects for Pure Selection 31
Materials and Methods 36
General Background 39
Conflicts, Doubts and Changes of Plans 41
The 'Genetic Turn' of IVF 41Ethical Discussion at the Local Level 44
Distrust within the Working Group 42
Ethical Criticism at Wahlström’s Unit 43
The Ethics Advisory Group 44Ethical Discussions at the National Level 48
Department of Clinical Genetics at the Sahlgrenska
University Hospital/East 47
Ban on Transfer of 'Experimental' Embryos 49Issues and Peculiarities 60
The Government Committee on 'the Unborn Child' 50
The Council for Medical Research 51
The Swedish Medical Association 51
The Swedish Society for Medical Genetics 52
Philosophical Treatment of PGD 52
The National Council for Medical Ethics 53
The Specialists 54
Powerplay and Tactics in the Government 56
Parliament 57
'Premature' Clinical Application 59
Unreflected Opposition 61Chapter 3: ARGUMENTS FOR PURE SELECTION 81
Why PGD for IVF-patients Only? 63
Confusion Regarding the Status of PGD 64
The Embryo Research Act Disarmed 65
Taking the Step from Research to Routine 67
The Problem of Local Ethical Action 76
Avoiding Abortion in Genetic Counselling 81
Genetic Counselling 81Improving IVF 90
Remaining Shortcomings of Prenatal Diagnosis 85
Embryo Destruction is not Abortion ? So What? 88
Restricted Applicability? 91Paving the Way for Better Treatment 94
Improving Birth-rates and Improving Quality 93
Treatment and Selection 95Chapter 4: THE MORAL STATUS OF EARLY EMBRYOS 102
Prevention and Autonomy 98
A Step Towards Treatment 100
Utilitarianism and the Destruction of Embryos 105
All Affected Parties are Important 105The Official Catholic Position 110
Lack of Potential for Enjoying Well-being 105
Early Embryos have Weaker Moral Status 107
What About Numbers? 108
The Argument from Divisibility 112The Relevance for Pure Selection of the Embryo Debate 117
Potentiality and Species Membership 114
The Morality of Risktaking 115
Pure Selection not Involving Embryos 117Chapter 5: IVF-RELATED OBJECTIONS 122
The Importance of Other Affected Parties 118
Embryos and PGD: from Ethics to Politics 119
The Value of Additional Children 123
Utilitarianism and Increases in Population 123Against Nature 137
The Repugnant Conclusion and the Non-identity Problem 125
The Appeal to Parental Responsibility 129
Supererogation and the Virtue of the Utilitarian View 134
Implications for Pure Selection 136
The Catholic Arguments Against IVF 138Information, Autonomy and Well-being 143
The Obscurity of the Unnatural 142
The Technologisation of Procreation 143
Three Cases for Restricting Autonomy 146Chapter 6: RISK OBJECTIONS 159
Are Autonomy Restrictions Absolutely Prohibited? 150
”Never as a Means Only” 151
Anti-paternalism 152
Utilitarianism 154
Utilitarianism and Autonomy at a Societal Level 155
Risks to Resulting Children 159
What Are the Risks? 160Risks to the Woman 169
Preliminary Considerations 161
No Harm Done ? No Wrong Done? 163
Wrong without Harm 166
What are the Risks? 170Pure Selection and Informed Consent 188
Preliminary Considerations 172
PGD as Infertility-treatment: First Round 174
Responsibility, Permissibility, Rationality and Autonomy 175
PGD as Infertility-treatment: Second Round 178
PGD for Selection Against Disorders 180
PGD for Selection of Non-medical Characteristics 183
But What if the Risks Can be Substantially Reduced? 187
Uncertainty, Ambiguity and Bias 190Chapter 7: PURE SELECTION IN SOCIETY 204
Two Views of Informed Consent 195
Autonomy, Rationality and Quality of Information 197
Who Should be Offered Pure Selection? 202
From Severe to Milder Conditions 205
The Selective Supermarket 210
Individual Choices 214Scenarios of Discrimination 235
Social Practice 218
Is the Selective Supermarket Eugenic? 230
State Pressures 236Chapter 8: REGULATING PURE SELECTION 246
The 'Backdoor Eugenics' Scenario 239
Research on Pure Selection 246
Why Bans on Research do not Work 247From Research to Clinical Application 250
The Importance of Public Funding 248
Privately Financed Research 249
A System for Control 251Pure Selection in Routine Health Care 255
The Content of the Control 252
Safeguarding the Quality of Routine Pure Selection 256GLOSSARY OF ABBREVIATIONS AND TECHNICAL TERMS 276
Pure Selection on Non-medical Grounds 258
Bans on Special Targets: 1. Unaffected Carriers 262
Bans on Special Targets: 2. Sex Preselection 264
Bans on Special Targets: 3. Sexual Orientation 266
Making Priorities within Health Care 269
Care and Support for the Sick, Disabled and Mentally Retarded 272
REFERENCES 284
INDEX 302